35% of Domestic Drug Makers Do Not Conduct First-in-Human Trials in Japan: JPMA Survey

The results of a questionnaire survey announced by the Japan Pharmaceutical Manufacturers Association (JPMA) on September 3 reveal that 35% of domestic pharmaceutical manufacturers do not conduct first-in-human (FIH) clinical trials in Japan. One reason cited by smaller drug makers...read more